A search for transforming genes expressed in brain led to the identi®cation of a novel isoform of Ost, an exchange factor for RhoA and Cdc42. In addition to the Dblhomology (DH) and pleckstrin-homology (PH) domains identi®ed in the original Ost, this isoform contained a SH3 domain and a novel HIV-Tat related (TR) domain. The presence or absence of these domains in Ost de®ned multiple isoforms of the protein. RT ± PCR and in situ hybridization analysis revealed that these isoforms were generated by tissue-speci®c and developmentally restricted alternative splicing events. Whereas deletion of the N-terminus activated the transforming properties of Ost, the presence of the SH3 domain reduced the transforming activity of the protein. This inhibition was relieved by the presence of a TR domain, which contained a potential SH3 ligand sequence. The transforming activity of all Ost isoforms was inhibited by dominant negative forms of the Rho family proteins. Expression of Ost isoforms potently induced the formation of actin stress ®bers and ®lopodia as well as JNK activity and AP1-and SRF-regulated transcriptional pathways. Ost transfectants also displayed elevated levels of cyclins A and D1, suggesting that the de-regulation of these cyclins is linked to Ost-mediated transformation.
Introduction
The Dbl homology (DH) family of proteins are comprised of at least 17 members which all contain a DH domain and in tandem with a pleckstrin homology (PH) domain (Zhon et al., 1998) . One of these members, Ost, was identi®ed as a transforming cDNA from osteosarcoma cells that was activated by Nterminal truncation (Horii et al., 1994) . The Ost protein contained DH and PH domains in its central region and was shown to function as a guanine nucleotide exchange factor of RhoA and Cdc42, small GTP-binding proteins of the Rho family. One of the functions of the Rho family of proteins is in the regulation of cytoskeletal organization underlying changes in cell motility and morphology; RhoA regulates formation of actin stress ®bers and focal adhesion complexes, whereas Cdc42 controls ®lopodia formation, a process which also involves cytoskeletal actin reorganization Kozma et al., 1995; Nobes and Hall, 1995) . Another member of the Rho family, Rac1 is required for membrane ruing induced by insulin, epidermal growth factor or platelet-derived growth factor ). An interesting feature of Ost is that it interacts speci®cally with the GTP-bound form of Rac1, suggesting that Ost functions as an eector of Rac1 (Horii et al., 1994) . Expression of Ost is highest in brain and is localized to the axonal processes of neurons and a-tanycytes which contain actin abundantly, suggesting that Ost may participate in axonal transport in these specialized cells by regulation of actin ®ber formation.
In addition to their roles in cytoskeletal reorganization, the Rho family of small GTPases have been demonstrated to be critical for cellular proliferation and malignant transformation. The activated Rho proteins stimulate DNA synthesis upon microinjection into quiescent ®broblasts and are necessary for progression through the G1 phase of the cell cycle (Olson et al., 1995) and these eects are separable from the role of these proteins in cytoskeletal regulation (Lamarche et al., 1996) . In addition, activating mutations introduced into Rac1 convert the GTPase into a transforming protein and dominant negative mutants of Rac1 and RhoA suppress Ras-induced transformation (Khosravi-Far et al., 1995; Qui et al., 1995) . More recently, it has been shown that RhoA and Ras signaling pathways are linked through p21/ WAF, a cyclin dependent kinase inhibitor, whose levels are modulated cooperatively by Rho and Ras proteins to allow cell cycle progression (Olson et al., 1998) . Thus, proteins that control the activity of RhoA, Rac1 and Cdc42, may have essential roles in the signal transduction pathways underlying cellular growth and transformation.
We have established an expression cloning system to isolate signaling molecules which can induce morphological transformation of NIH3T3 ®broblasts (Miki et al., 1991) . Using this approach we identi®ed a novel isoform of the Ost oncoprotein containing a SH3 domain as well as unique domains. We show that alternative splicing generated multiple Ost isoforms with restricted and overlapping patterns of expression, with highest expression of all isoforms within the central and peripheral nervous systems. These isoforms of Ost displayed varying transforming activity to mouse ®broblasts but equally stimulated the produc- Alignments of the EN domain and N domain, respectively, to similar sequences. Initial alignments of Ost were generated using the BLAST algorithm and composite alignments were performed manually. Dashes indicate gaps introduced to maximize the alignments. Residues identical or homologous to Ost are shaded and numbers mark amino acid position within the aligned proteins. The accession numbers for sequences used to generate the alignments are: Tat (P12512), RAG8 (P40230), Ril, (Y08361), Ncf-1 (P14598), STK/p57 (P17713), c-Abl (M13099), Rak (U22322), F49E2.3 (Z46267), Tim (U02082), Trio (U42390), P-Cip10 (U88156), Spectrin (P07751) and Fodrin (M18627) tion of actin stress ®bers. Ost isoforms regulated several parameters of RhoA, Rac1 and Cdc42 function and dominant negative mutants of these proteins blocked Ost-mediated transformation. These ®ndings identify a family of Ost proteins produced by alternative splicing which regulate Rho-family mediated signaling.
Results

Identi®cation of transforming genes expressed in rat brain
To identify transforming genes expressed in brain, a cDNA library constructed from a 6-day-old rat brain in the lpCEV29 eukaryotic expression vector was ampli®ed, DNA extracted, and used to transfect NIH3T3 cells. Among the foci of morphologically transformed cells that appeared, thirty showed G418 resistance, which indicated integrated vector sequence. The plasmids were rescued from these cells and used to transfect NIH3T3 cells to identify the plasmids with high-titered transforming activity. The cDNA inserts of plasmids with high-titered transforming activities were subjected to sequence analysis from their 5'-ends using a vector primer. The majority of the transforming genes isolated in this procedure were in the ras and raf families. Interestingly, several of these foci contained both wild-type B-raf and ras cDNAs suggesting that these proteins can synergize to transform NIH3T3 cells. Two other oncogenes, c-fms and ost, were identi®ed as transforming cDNAs. The c-fms cDNA, encoding the colony stimulating factor 1 (CSF-1) receptor, contained the entire coding sequence. Since mouse CSF-1 is synthesized and secreted from NIH3T3 cells (Roussel et al., 1987) , ectopic expression of its receptor may have created an autocrine loop resulting in morphological transformation. We have previously identi®ed ost as a transforming cDNA from osteosarcoma cells whose transforming activity can be potently increased by N-terminal truncation (Horii et al., 1994) . Analysis of the ost cDNA from neonatal brain revealed that it also encoded an N-terminally truncated protein but contained additional sequences when compared to the original Ost and was therefore analysed further.
Two novel isoforms of Ost are expressed in rat brain
The entire sequence of the cDNA for Ost from brain, designated Ost-b, revealed that it contained two inserts which were not found in the original Ost, designated Ost-a (Figure 1a) . The ®rst insert consisted of 75 nucleotides encoding 25 amino acids and was located C-terminal to the PH domain (Figure 1b ). This insert displayed homology to the HIV-encoded Tat protein (44% homology) and a yeast casein kinase homolog, RAG8 (accession number P40230; 48% homology), and therefore was designated the TR (Tat/RAG8-related) domain. The TR domain was also 40% homologous to a region of Ril, a novel LIM domaincontaining protein. The TR domain of Ost contained a potential SH3 ligand sequence (PTSP) followed by a charged series of residues (DKKAKRHEVKSD), both of which were conserved in the corresponding regions of Tat, RAG8 and Ril proteins. Further database searches identi®ed additional proteins, including several transcription factors, containing regions homologous to a TR domain (data not shown) suggesting a conserved function of this domain in these proteins.
The second insert of Ost-b showed homology with the N-terminal half of a SH3 domain (Figure 1c) . Interestingly, the latter half of the SH3 domain was encoded by the 3'-untranslated (UT) sequence of Ost-a cDNA, but was not in-frame and therefore not translated into coding sequence in the previously identi®ed Ost-a (Figure 1c) . The presence of the insert encoding the ®rst half of SH3 domain in Ost-b results in a frameshift allowing the translation of the 3'-UT sequence. In addition to the SH3 domain, the new reading frame also results in the translation of a unique C-terminal domain (C') of 37 amino acids not present in Ost-a (Figure 1a) . The amino acids comprising the SH3 domain of Ost displayed high homology with the sequences of other SH3 domains (Figure 1c ), including that of several Src-related kinases.
To investigate the expression pro®le of the Ost-a and -b isoforms, we performed RT ± PCR analysis using domain-speci®c primers of Ost in adult rodent tissues ( Figure 2a ). Using primers to amplify a region common to all isoforms, the central portion of Ost with the DH and PH domains, revealed the presence of Ost mRNA in all tissues analysed with the exception of adult spleen (Figure 2b, left panel) . Analysis of the expression of Ost isoforms containing a SH3 domain displayed a similar pattern of expression, with the exception of ROS cells, which showed no detectable expression of SH3-containing Ost. These results suggest that most isoforms of Ost contain a SH3 domain while the expression of Ost-a lacking the SH3 domain is restricted to osteosarcoma cells. Similar analysis for the TR domain showed that the expression of Ost isoforms containing this domain was restricted to a more limited number of the adult tissues analysed including brain, cerebellum, testis, lung, kidney and intestine. Interestingly, brain and cerebellum appeared to abundantly express two Ost isoforms containing the TR domain, whereas testis, lung and intestine faintly expressed a single isoform. Detailed analysis of the PCR bands generated from brain mRNA revealed that the lower band was identical to the one expressed in testis, but in addition to this 495 bp band, a product of approximately 570 bp was also detected in brain and cerebellum mRNA (Figure 2c ). This suggested the presence of a brain-speci®c isoform of Ost containing a TR domain and an additional domain, designated the brain insert (BI) sequence. The larger ampli®cation product from brain was subcloned and sequenced to identify the new sequence. Sequence analysis revealed that this cDNA contained an additional 93 bp sequence encoding an unique 31 amino acid insert that was N-terminal of the TR domain (Figure 2d ). Of the clones analysed, all cDNAs encoding a BI domain also contained an adjacent TR domain. To distinguish between Ost isoforms containing a TR domain alone or a TR domain plus a BI sequence we hence designate these isoforms as Ost-b1 or Ost-b2, respectively (see Figure 2a) . The predicted amino acid sequence of the brain insert in Ost-b2 displayed highest similarity to that of the alternatively spliced exon v6 of CD44 (45% homology) and to a region of the protein kinase C substrate, MARCKS (52% homology), two proteins involved in cytoskeletal organization (Figure 2d ).
Another isoform, Ost-g, is ubiquitously expressed RT ± PCR analysis suggested that an Ost isoform containing the SH3 domain is more widely expressed than Ost-a, an isoform lacking this domain (Figure 2b ). We isolated a cDNA for this Ost isoform, designated Ost-g, from a mouse hematopoietic cell line 32D. Sequence analysis revealed that Ost-g contained the SH3 domain but not the TR domain as expected (see Figure 1a) . Database searches revealed that the open reading frame of Ost-g was identical to that of a mouse Dbl-related protein, Dbs (Whitehead et al., 1995) . Ost-a was identical to Ost-g with the exception of an SH3 domain and an additional sequence of 189 amino acids, designated the extended N-terminus (EN domain), at the N-terminus of Ost-g, suggesting that Ost-a and Ost-g are alternatively spliced gene products diering in both C-terminal and Nterminal domains. Database searches for motifs in the EN domain revealed that this domain was most similar to the amino termini of Trio (57% homology) and P-CIP10 (53% homology, Figure  1d ) proteins which also contain DH and PH domains. Similar searches on the N domain of Ost revealed homology to the repeat sequences in spectrin (38% homology) and fodrin (36% homology, Figure 1e ). RT ± PCR analysis of Ost isoforms RNA isolated from adult rodent tissues or cell lines was subjected to RT ± PCR analysis using the indicated primer sets for Ost or b-actin (left panel). The same analysis was performed on RNA isolated from whole mouse embryos from embryonic days 7 through 17 (right panel). The position of DNA markers for each gel is indicated between the panels. (c) Identi®cation of a brainspeci®c isoform of Ost. RT ± PCR was performed on adult mouse testis and brain RNA using primer sets to amplify the region of Ost between to PH and TR domains. (d) The nucleotide and predicted amino acid sequence of the brain insert (BI) sequence. Amino acid comparison of the BI sequence to MARCKS (accession number P26645) and CD44 (accession number 1845366) is shown below the sequence containing the N or EN amino termini revealed that most tissues express mRNAs containing either N-terminus. Consistent with the cDNA clones isolated, ROS cells (Horii et al., 1994) and 32D cells (Whitehead et al., 1995;  this study) expressed mRNAs encoding Ost isoforms with the N or EN amino terminus, respectively (Figure 2b ). These results indicate the presence of multiple isoforms of Ost which contain unique C-terminal or Nterminal domains and display discrete patterns of expression.
Expression of ost isoforms is developmentally regulated
We next investigated the temporal expression pro®le of the Ost isoforms during mouse development. Total RNA was isolated from whole mouse embryos and subjected to RT ± PCR analysis using domain speci®c primers of Ost. The central region of Ost, which is common to all the isoforms, was detected as early as embryonic day (E) 7 and was maintained throughout embryonic development. (Figure 2b , right panel). Using a primer set which can hybridize to sequences encoding the PH and SH3 domains, Ost-g was similarly detected as early as the seventh day of development. Interestingly, using these same primers, multiple bands became apparent at E11 and were present until E17. Since these primers would also amplify Ost mRNA encoding TR and BI domains, we performed RT ± PCR analysis to amplify Ost mRNA encoding the TR domain. Similar to the observations in adult tissues using this primer set, two ampli®cation products were detected but their expression was ®rst observed at E11 and continued throughout development. No expression of these mRNA species was observed from E7 through E10, although these tissues did express other isoforms of Ost. These results indicate that the expression of Ost isoforms containing the TR domain and BI domain is restricted to mid and late stages of embryonic development in the mouse.
Ost isoforms are highly expressed in the central and peripheral nervous systems RT ± PCR analysis of Ost gene expression suggested that Ost isoform expression was segregated in some tissues and overlapped in others. To clarify the expression of Ost transcripts, in situ mRNA hybridization was performed on serial sections prepared from mouse embryos. Domain-speci®c riboprobes were generated for the SH3, TR, BI domains of Ost and used to detect Ost-g, Ost-b1 and Ost-b2 transcripts, respectively. We used relatively small domain speci®c riboprobes (75 ± 100 nucleotides) and high stringency conditions to decrease the possibility of detecting homologous sequences. In situ hybridization of these probes was ®rst performed on E12 mouse embryos, a developmental stage in which expressed all Ost isoforms. Hybridization of a SH3-or TR-domain speci®c riboprobe to E12 sections showed modest expression of these isoforms in several developmental structures of the embryo (Figure 3a ). In addition, dramatic expression of these Ost isoforms was observed within the peripheral and central nervous systems (PNS and CNS, respectively). At this developmental stage, Ost-g and Ost-b1 transcripts were highly expressed in dorsal root ganglion (DRG), spinal cord, as well as in the primordial structures of the telencephalon, cervical ganglion and pituitary ( Figure 3a ). In addition, less intense expression of these isoforms was observed in the primordial structures of liver, gut, lung and heart. In addition to the structures detected by the SH3-and TR-speci®c probes, a riboprobe speci®c for Ost-b2 mRNA, detected expression of this transcript in developing tail somites, vibrissa, and maxillary tissue (Figure 3a) , suggesting that Ost mRNA expression is restricted to the Ost-b2 isoform in these tissues.
Examination of Ost mRNA by in situ hybridization was also performed using these riboprobes on serial sections prepared from E16 mouse embryos. Similar patterns of expression for the g, b1 and b2 isoforms were observed in this developmental stage, with all the isoforms being expressed in lung, kidney, heart, liver, thymus, pituitary, and central nervous system (Figure 3a) . Consistent with its restricted expression at E12, Ost-b2 was also expressed at higher levels in maxillary tissue and independently in the hind limb. Interestingly, whereas expression of Ost isoforms in the DRG at E12 was detected in both anterior and posterior DRG, at E16 the expression within the DRG was con®ned to the posterior structures. Higher magnifications of both E12 and E16 autoradiographs revealed a segregated distribution of Ost within the both CNS and PNS. At E12, all Ost isoforms were highly expressed in the telencephalon as well as in the structures which give rise to the spinal cord, cerebellum, thalamus, hippocampus, cervical ganglion, and pituitary gland. This expression was more pronounced at E16 with these structures showing high expression compared to sense probe controls. In addition, at E16 Ost displayed high expression in the cortex, hippocampus, thalamus as well as in ectoturbinates, a developmental structure which give rise to structures involved in olfaction. Collectively, these results indicate that expression of Ost isoforms display both independent and overlapping distribution patterns in mouse embyrogenesis.
We sought to explore the CNS expression of Ost in more detail by performing in situ analysis on coronal sections of adult mouse brain. SH3-, TR-and BIcontaining isoforms of Ost displayed prominent staining of certain subregions of the adult brain as well as a diuse expression patterns throughout the CNS (Figure 3b ). Consistent with the gene's expression in these CNS structures during development, Ost was detected in the limbic system, with the dentate gyrus and CA1-3 regions of the hippocampus showing highest expression. High Ost expression was also observed in the hypothalamic, thalamic and cortical regions (Figure 3b ). These observations indicate the overlapping expression of Ost isoforms and highlight a specialized role of Ost within these subregions of the CNS.
SH3 and TR domains modulate the transforming activity of Ost
The presence of newly identi®ed domains may aect the transforming activity of Ost. Since the BI domain was identi®ed only in RT ± PCR analysis, this analysis was con®ned to the SH3 and TR domains. Since Ost displays a marked increase in transforming activity to ®broblasts upon removal of the N-terminal domain (Horii et al., 1994) , we ®rst tested the truncated forms (T) of Ost-a, b1, and g in focus forming assays. Interestingly, whereas Ost-a (T) displayed potent transforming activity (44610 4 f.f.u. pmol DNA), transfection of the Ost-g (T) cDNA displayed markedly lower transforming activity (5610 3 f.f.u./ pmol DNA), suggesting that the presence of the SH3 domain in this isoform is inhibitory to transformation (Figure 4a ). However, Ost-b1 (T), which contains the TR domain in addition to the SH3 domain, displayed potent transforming activity similar to that of the Ost-a (T). These results are not likely to be attributed to dierent expression levels, since these constructs displayed similar levels of protein expression. Therefore, the presence of the TR domain in Ost-b1 (T) may Figure 4a ). The lower transforming activity of Ost-g (F) containing the EN domain suggested that the presence of the EN domain does not inhibit the negative regulatory role of the N domain.
Inhibition of Ost-transformation by dominant-negative mutants of rho GTPases
Ost can catalyze the GDP/GTP exchange on RhoA and Cdc42 and can interact speci®cally with the GTPbound form of Rac1 (Horii et al., 1994) . To examine the role of these GTPases on Ost-mediated transformation, we cotransfected NIH3T3 cells with Ost isoforms and Rho family expression vectors or empty vector. Expression of wild-type RhoA, Rac1 or Cdc42 did not alter Ost-induced transformation as compared to vector controls (data not shown). When the dominant-negative counterparts of these proteins are used, strong inhibition of transformation was observed ( Figure 4b ). The transforming activity of the a, b, and g isoforms were equally inhibited by the dominant negative GTPases and no signi®cant dierences in speci®city were observed among the isoforms. Coexpression of these dominant negative Rho proteins did not signi®cantly reduce the transforming activity of a constitutively active form of ®broblast growth factor 2 (FGFR2-FRAG1; Lorenzi et al., 1996) (data not shown), suggesting that the inhibition by dominant negative Rho proteins is speci®c to Ost-mediated transformation. These results indicate that the Rho family GTPases play a central role in Ost signaling towards cellular transformation.
Ost isoforms activate JNK but not ERK or p38 MAP kinase in NIH3T3 cells
We have previously shown that Ost as well as mutationally activated forms of its substrate, Cdc42, can activate JNK, but not ERK, MAP kinase cascades in a COS cell transient expression system (Coso et al., 1995) . To investigate MAP kinase activation by dierent isoforms of Ost in NIH3T3 cells, we established G418-selected stable ost-transfectants. Western blot analysis with anti-Ost antibodies showed that these stable transfectants expressed Ost isoforms at comparable levels ( Figure  5a ). In addition, the observed size of Ost protein detected in the cell lines correlates with the size predicted from the primary sequence of the transfected Ost cDNA [Ost-a (F), 110 kD; Ost-a (T), 63 kD; Ost-g (F), 130 kD; Ost-g (T), 85 kD; and Ost-b1 (T), 78 kD]. We ®rst analysed endogenous JNK activity in the stable transfectants of Ost using an in vitro kinase assay. In transfectants containing vector alone, a very low level of JNK activity was observed (Figure 5b ). The activity of JNK in these cells was dramatically increased by stimulation with anisomycin. The activity of JNK was also increased in cells expressing Ost. All truncated isoforms displayed a high level of JNK activity with inductions over unstimulated vector transfectants of 3 ± 4-fold. In contrast to the transforming activity, no signi®cant dierences were observed in JNK activation among the cells expressing dierent Ost isoforms. The N or EN plus N domains present in the Ost-a or -g isoform, respectively, could inhibit the transforming activity in NIH3T3 cells (see Figure 4a) . However, JNK activation by Ost-a was not signi®cantly inhibited with the N domain (Figure 5b ). In contrast, while the expression of the Ost-g (T) resulted in strong activation of JNK, expression of Ost-g (F) induced only a slight increase in JNK activity. Since the Ostg (F) contained the EN domain, this domain may inhibit the JNK activation by Ost. We extended this analysis to another stress-activated MAP kinase, p38. The activity of p38 in ost- transfectants was assessed by Western blotting for the active form of p38. In vector alone transfectants, no signi®cant amount of activated p38 kinase was detected, indicating that the basal activity of this kinase is very low in these cells (Figure 5c ). Upon stimulation with UV light or anisomycin, a dramatic increase in p38 activity was observed. In contrast, no elevation of p38 activity was evident in Ost-expressing cells. Stimulation of ost-transfectants with anisomycin resulted in activation of p38 to a comparable level as Western blot analysis of lysates of ost-transfectants using antibodies speci®c to the phosphorylated form of p38 (c, upper panels) or p42/p44 (d, upper panel). Ultraviolet (UV) stimulation or anisomycin (A) were used to stimulate p38 activation in (c). (Lower panels) Blots were stripped and reprobed with antibodies against either p38 (c) or p42/p44 (d) to determine the levels of these proteins in the lysates. (e) Ost stimulates SRE and AP-1 transcriptional activity. NIH3T3 cells were transiently transfected with SRE-Luc or AP1-Luc reporter plasmids and empty expression vector, full-length or truncated Ost isoforms, or activating mutants of Ras, Rac1, or RhoA, as indicated. Luciferase activity was normalized to the amount of protein in each lysate and expressed as relative luciferase activity. The luciferase activity in unstimulated vector transfected cells was assigned the value of 1. Vector transfected cells were stimulated with 10% FCS or 100 ng/ml TPA to assess the activity of the SRE-Luc and AP1-Luc reporter plasmids, repectively, in these cells. The results shown are the average of 4 ± 6 independent experiments UV-stimulated transfectants, indicating that the kinase is able to undergo activation in these cells (data not shown). We also compared the endogenous activity of the ERK MAP kinases, p42/p44, in the stable transfectants. Consistent to the observation in transient COS cell systems (18), stable expression of Ost-a (T) did not result in the elevation of ERK activity (Figure 5d) . Other truncated or full-length Ost isoforms did not induce ERK activity signi®cantly, whereas stable expression of an activated H-Ras or stimulation with ®broblast growth factor resulted in activation of these kinases. These results indicate that the expression of Ost speci®cally activates JNK but does not eciently activate the ERK1/ERK2 or p38 MAP kinase cascades.
Ost isoforms stimulate transcriptional activity through AP-1 and SRF
The activation of Cdc42, Rac1 and RhoA should result in a signaling cascade culminating in the transcriptional activation by AP-1 and serum response factor (SRF) (Hill et al., 1995) . To examine the role of these transcriptional pathways in Ost signaling, serum response element (SRE) -and AP1-binding siteluciferase reporter plasmids were used to monitor the activity of both AP-1-and SRF-mediated transcription, respectively, upon coexpression of either fulllength or truncated Ost. To measure TCF-independent SRE activation the SRE.mut.L sequence (Hill et al., 1995) was used as SRE. As shown in Figure 5e , expression of the truncated isoforms of Ost potently induced the transcriptional activity of this SRE reporter plasmid displaying an activity higher than that of serum-stimulated cells or cells expressing a mutationally activated RhoA (V14) protein. In contrast to the truncated proteins, the full-length forms containing N or N plus EN domains [Ost-a (F) and Ost-g (F), respectively] exhibited lower activity, suggesting that these domains negatively aect transcriptional regulation by Ost. Similar to the results obtained using a SRE reporter plasmid, the expression of the truncated Ost isoforms increased the transcriptional activity by AP-1 with similar increases observed for all three isoforms, while the full-length isoforms showed moderate activity (Figure 5e ). The activity of the truncated isoforms was comparable to that of cells stimulated with phorbol ester or expressing activated H-Ras or Rac1 proteins. These results indicate that the early transcriptional events mediated by Cdc42, Rac1 and RhoA proteins can be potently activated by Ost.
Induction of cyclin expression by Ost isoforms
Activation of Rho family of GTPases is required for progression through G1/S phase of the cell cycle (Olson et al., 1995) . To determine if Ost aected the components of the cell cycle machinery, we ®rst analysed the expression levels of cyclin D1, a pivotal cyclin involved in G1/S transitions, by Western blot analysis of serum-deprived Ost-transfectants. Expression of activated forms of the GTPases Ras, RhoA, Rac1 and Cdc42 resulted in an increase (3 ± 8-fold) in the expression of cyclin D1 compared to that of vector-containing transfectants (Figure 6 ). Cyclin D1 levels were also elevated in Ost-expressing cells.
Expression of N-terminally truncated Ost-a and g isoforms increased cyclin D1 levels (eight-and ®vefold, respectively). In contrast, cyclin D1 levels were not signi®cantly elevated in Ost-b-expressing cells. Similar increases in cyclin D1 levels were also observed for both full length a and g isoforms (3 ± 5-fold), suggesting that the presence of the EN domain does not dramatically aect this pathway. Reprobing of these membranes with anti-Ost revealed that the isoforms were highly expressed at dierent degrees ( Figure 6, bottom panel) . When normalized to Ost expression in these cells, the ordering of the activity of the truncated isoforms on cyclin D1 accumulation is Ost-a (T)44 Ost-g (T)4Ost-b(T). These results indicate that similar to Rho family proteins, Ost expression can upregulate the expression of cyclin D1.
To further investigate changes in cyclin expression in the Ost-transfectants, protein levels of cyclin A, a cyclin upregulated in S phase and involved in G2/M cell cycle progression, were also determined. Interestingly, expression of Ost-a (T), Ost-b (T) or Ost-g (T) all resulted in signi®cant increases in cyclin A protein levels (approximately fourfold) in serum-starved cells compared to vector controls. Cyclin A levels were also modestly elevated in Ost-a (F) (twofold) but not in Ost-g (F)-expressing cells. In contrast to what was observed for cyclin D1, expression of activated Rho family GTPases did not result in increases in cyclin A protein levels compared to vector controls, suggesting that these GTPases do not eciently couple with the pathways leading to cyclin A elevation in these cells. Reprobing of the same membranes with anti-cyclin D2 (data not shown) or with anti-Cdk5 revealed constant levels of these proteins in the transfectants. When normalized to protein expression, Ost-induced elevation of cyclin A expression assumed the order Ost-a-(T)4Ost-b (T)4Ost-g (T). As no signi®cant increases in cyclin A protein levels were observed by expression of Rho family GTPases, induction of this cyclin by Ost isoforms appears to be independent of the activation of Rho family proteins.
Induction of actin stress ®ber and ®lopodia formation by Ost
Activation of Cdc42 and RhoA results in the formation of ®lopodia and contractile actin stress ®bers, respectively Kozma et al., 1995; Symons et al., 1996) . To determine if Ost could regulate these processes, we visualized ®lamentous (F) actin content in serum-starved NIH3T3 transfectants using a¯uorescent derivative of phalloidin. Few actin stress ®bers were present in serum-starved cells stably transfected with vector alone, whereas dramatic increases in F-actin were observed upon stimulation Figure 7 Ost stimulates actin stress ®ber and ®lopodia formation. (a) F-actin formation in serum-starved ost-transfectants. Cells remaining in serum-free conditions after 18 h or cells exposed to 10% FCS prior to staining with rhodamine-conjugated phalloidin are indicated by (7) and (+), respectively. Ost-a (F)-and Ost-g (F)-expressing cells were also stimulated with serum as described to visualize increases in F-actin content in these transfectants. Actin stress ®bers were also analyzed in cells expressing full-length and truncated isoforms of Ost and in cells expressing RhoAV14, Cdc42V14, or Ras V12. (b) Induction of ®lopodia by Ost. Representative cell populations from Ost-a (T) and Ost-g (T) transfectants displaying ®lopodia. Cells were stained with rhodamineconjugated phalloidin as described in a. Arrows indicate areas of ®lopodia formation in both a and b with serum (Figure 7a ). Stable expression of RhoA (V14) resulted in an increase in the steady-state levels of actin stress ®bers in serum-starved cells, but fewer stress ®bers were observed in Cdc42-expressing cells (Figure 7a, bottom row) . When the same analysis was performed on cells expressing Ost isoforms, stress ®ber formation was potently increased in serum-deprived cells expressing the truncated Ost isoforms compared to that of vector controls (Figure 7a) . No signi®cant dierence in the activity to increase F-actin among the truncated Ost isoforms was observed. Interestingly, cells expressing full-length Ost-a also displayed increases in stress ®bers, while cells expressing Ost-g (F) were indistinguishable from vector controls ( Figure  7a ). These results suggested that the EN and N domains present in Ost-g (F) can inhibit the function of Ost in regulating actin stress ®ber formation, while the N domain alone lacks such activity in these conditions. Both of these cell lines did exhibit increases in stress ®ber formation following serum stimulation (Figure 7a ), indicating that the formation of actin stress ®bers can be activated further in these cells. No stress ®bers were observed in H-Ras V12 transformed cells, consistent with cytoskeletal disorganization induced by the expression of this oncogene. Since Ost can also stimulate nucleotide exchange on Cdc42, we analysed cells for the formation of ®lopodia, actin-based membrane extensions regulated by this GTPase. Multiple ®lopodia were observed in cells expressing a mutationally activated Cdc42 protein (Figure 7a ), indicating that constitutively active Cdc42 can increase the steady-state levels of ®lopodia in these stable transfectants. Increases in ®lopodia were also observed in cells expressing the truncated isoforms of Ost (Figure 7b ) but not in vector-containing cells (data not shown). The increased formation of actin stress ®bers and ®lopodia in cells expressing activated Ost indicate that this protein can stimulate the signaling pathways underlying these cytoskeletal processes.
Discussion
We have identi®ed multiple isoforms of Ost which dier in unique modular domains. One of the isoforms identi®ed contained a SH3 domain and a previously undescribed motif, designated the TR domain. The TR domain in Ost was most similar to regions of the Tat protein of HIV (Choi et al., 1997) , Ril, a gene downregulated in H-ras-transformed cells (Kiess et al., 1995) , and a casein kinase homolog, Rag8, of unknown function. Interestingly, a potential SH3 ligand sequence, (R/K)XXPXXP, present in the TR domain of Ost is conserved in these proteins suggesting that this sequence can also bind SH3 domains. Another Ost isoform, Ost-b2, contained an additional unique sequence motif, the BI domain. The BI domain was most homologous to a calmodulin binding domain in MARCKS (Seykora et al., 1991) , a protein kinase C substrate, and to an alternatively spliced domain of CD44, an extracellular matrix receptor for hyaluronic acid, which when contained in CD44 imparts increased metastatic potential (Naor et al., 1997) . Interestingly, both of these proteins can participate in the crosslinking of F-actin (Hartwig et al., 1992; Naor et al, 1997), suggesting a conserved function of this domain in regulating the cytoskeleton. An additional isoform, Ost-g, was identifed which contained an extended amino terminus and SH3 domain, but not TR or BI domains. These isoforms displayed distinct and overlapping patterns of expression in adult tissues and during embryogenesis. Since we have partially cloned the ost gene and identi®ed the exons encoding BI, TR and SH3 domains (unpublished results), these isoforms appear to be generated by alternative splicing.
We observed that Ost-a, an isoform lacking the SH3 domain, displayed an elevated transforming activity compared with Ost-g, an isoform containing this domain. Another isoform Ost-b containing both the TR and SH3 domains showed a weak transforming activity. These results may suggest that the SH3 domain reduces the transforming activity of Ost and the TR domain suppresses the inhibitory eect of transformation by SH3. In this case, the TR domain may exhibit such activity by directly interacting with the SH3 domain, since the TR domain contains a potential SH3 ligand sequence. A similar intramolecular regulation of SH3 domain function has been reported for the tyrosine kinases, Itk and Abl by binding of its SH3 domain to adjacent proline-rich sequences (Hamilton-Andreotti et al., 1997; Barila and Superti-Furga, 1998) . It is interesting to note that the arrangement of the SH3 domain and SH3 ligand sequence in Ost is similar to these kinases, suggesting a conserved regulatory mechanism between these proteins. In this regard it will be of interest to examine the possible TR-SH3 interactions using site-directed mutagenesis.
We previously identi®ed Ost-a to be highly expressed within the central nervous system with intense staining of axonal processes in rodent brain (Horii et al., 1994) . We have extended these observations by localizing Ost isoforms using domain-speci®c probes using in situ hybridization. In addition to detecting Ost transcripts in the hypothalamus, Ost isoforms were highly expressed within the same structures in PNS and CNS. This colocalization of Ost isoforms within the same tissues suggests the coexpression of Ost isoforms within the same cell types. As a potential SH3-TR intramolecular interaction has been observed for the transforming activity of Ost-b, it is interesting to speculate that Ost isoforms may hetero-or homodimerize to regulate its activity.
The signaling pathways emanating from Cdc42, Rac1 and RhoA have been shown to induce cellular transformation and the activity of these proteins is critical for the transforming activity of several oncogenes including ras (Khosravi-Far et al., 1995; Qui et al., 1995) . Transformation by Rho family proteins is thought to activate speci®c transcription factors by Rho-family mediated kinase cascades. The activity of two of these factors, AP-1 and SRF, is increased in response to Cdc42/Rac1/RhoA activation and such increases are associated with the transforming activity of a variety of oncogenes including v-src, tprmet and the trimeric G-protein subunit, Ga12 (Minden et al., 1995; Rodrigues et al., 1997; Tolkacheva et al., 1997) . In line with these observations, Ost isoforms stimulated both AP-1 and SRF-mediated transcription similar to that of Rho family members and the ability of the full-length isoforms versus the truncated counterparts to activate these pathways correlates with their transforming activity. Also consistent with the function of Ost in promoting the exchange activity of Cdc42 and RhoA (Horii et al, 1994) , we observe that the transforming activity of all Ost isoforms was potently inhibited by coexpression of dominant negative mutants of the Rho family GTPases. In contrast, Ost can not activate Rac1 in vitro, but can interact with the GTP-bound state of the protein.
Coexpression of dominant negative Rac1 mutants, which have a high anity for GDP, may block Ostmediated transformation through the inactivation of Ost protein directly by its binding to Ost. Alternatively, activation of Cdc42 or RhoA by Ost may in turn activate Rac1 and the activity of Rac1 is necessary for transformation by Ost. Interestingly, we did not observe a steady state increase of lamellipodia in Ost transfectants (unpublished observations), suggesting that Ost binding to GTP-bound Rac1 dampens this aspect of Rac1 activity. Nonetheless, further support that Ost activates these GTPases comes from the observation that Ost expression also increased the steady-state levels of ®lopodia and actin stress ®bers in ®broblasts, processes regulated by Cdc42-and RhoAmediated signaling, respectively. Taken together, these observations provide further evidence that Ost can regulate Cdc42-, Rac1-and RhoA-mediated signaling events in vivo.
Multiple spectrin-like repeat sequences were identi®ed in the N domain of Ost. Spectrin is a SH3-domain containing protein which provides structural support to the plasma membrane by linking speci®c integral membrane proteins to the cytoskeleton through the binding of actin ®laments (Viel and Branton, 1996) . Interestingly, the EN domain of Ost was most similar to the N terminal regions of Trio and Kalirin/p-CIP10, two proteins which bind to integral membrane proteins and also contain spectrin-like repeat sequences (Alam et al., 1996; Debant et al., 1996) . Moreover, ectopic overexpression of isoforms containing the EN and/or N domains resulted in dierences in the localization of Ost within the cytoplasm (unpublished observations), suggesting that these domains, possibly together with the SH3 domain, may alter the ability of the protein to interact with cytoplasmic targets. Such changes in localization may impact the signaling properties of the protein. Indeed, while the presence of the EN and/or the N domains inhibited Ost-induced transforming activity and transcriptional activation, the presence of EN domain (but not N domain) in Ost was inhibitory to the formation of actin stress ®bers. In this regard it will be of interest to examine in detail the contribution of the various domains of Ost in the subcellular localization of the protein and if possible dierences in localization underlie the distinct signaling properties of Ost isoforms.
Activated Ost isoforms displayed unique transforming properties to rodent ®broblasts but yet equally stimulated actin-based cytoskeletal changes. Although striking dierences amongst the isoforms were observed for AP-1, SRF and JNK activities or cyclin A/ D1 upregulation, there was a general correlation between the activity of full length (low) versus the truncated counterpart (high) on these pathways. A recent study reports that the expression of activated Ost-g/Dbs results in up-regulation of cylcin D1 protein and promoter activity and these activities correlate best with the transforming potential of the protein (Westwick et al., 1998) . Accordingly, we also observed increases in cyclin D1 expression upon expression of activated Ost but Ost-b did not exhibit a strong correlation between its transforming activity and cyclin D1 levels. Unexpectedly, we also observed increases in cyclin A levels by Ost but not by Rho family proteins. This suggests a novel function of Ost to induce cyclin A by an unknown mechanism, independently of activation of the GTPases. Taken together, these observations suggest that Rac/JNK/AP-1, RhoA/SRF pathways and/or cyclin A or D1 accumulation are involved to some degree in Ost-mediated transformation and cytoskeletal changes but other factors such as subcellular localization or availability of binding proteins can modulate the dierences in transformation. Along these lines we have identi®ed several proteins which bind speci®cally to Ost-a (MVL and TM, unpublished observations) and it will be of interest to determine if dierences in binding properties exist amongst the isoforms for these Ost-interacting proteins.
Materials and methods
Construction of an improved expression vector lpCEV29
A new expression vector, lpCEV29, was engineered to include: increased expression capability in COS cells, a Cre/ loxP plasmid excision system, and an additional restriction site, PacI, in the multiple excision sites (MES) for plasmid rescue. Expression of cDNA insert in the previous expression vector pCEV27 (Miki et al., 1991) in COS cells was relatively poor due to deletion of a S®I site in the T-antigen binding site present in the SV40 origin of replication. The insertion of oligonulceotides in this region, recreated the T-antigen binding site but the generation of a S®I site in this region was avoided by a mutation in the inserted oligonucleotide. Oligonucleotides, TM205 and TM206, containing a new MES and a loxP recombination site were inserted at the NotI site in this plasmid to create pCEV29. l arms were prepared from lpCEV2 by NotI cleavage and ligated with NotI-cleaved pCEV29 via an additional copy of the MES/loxP sequence. l particles were generated by in vitro packaging (Stratagene) and each plaque was tested for plasmid excision by the Cre/ loxP system. One of the l clones which could be converted to plasmid form contained the TM205/TM206 sequence in both the l-plasmid junctions and was designated lpCEV29. The oligonucleotides used had the following sequences: TM205: 5'-GGCCGCTCGAGTTAATTAACGCGTAATATAACTT-CTATAATGTATGCTATACGAAGTTATTA and TM206: 5'-GGCCTAATAACTTCGTATAGCATACATTATACGA-AGTTATATTACGCGTTAATTAACTCGAGC.
Expression cloning
A cDNA library was prepared in lpCEV29 using 10 mg of poly(A) + RNA isolated from a six day old rat brain as described (Miki et al., 1991) . Library DNA was ampli®ed and a portion (100 mg) was used to transfect 10 plates of NIH3T3 ®broblasts by standard calcium phosphate precipitation. Approximately 14 days following transfection, transformed foci were isolated and grown in the presence of 750 mg/ml G418 (GIBCO ± BRL) to select stably integrated plasmid sequences. Plasmid DNA was rescued as described (Miki et al., 1991) and subjected to DNA sequence analysis.
Gene expression analysis
First strand cDNA was synthesized by reverse transcription of total RNA (10 mg) isolated from adult rodent tissues or cell lines or from whole mouse embryos. First strand cDNA was also prepared from poly(A) + RNA (0.5 mg) isolated from lung, liver, testis, spleen, skeletal muscle, heart, and kidney tissues. PCR was used to amplify cDNA with primer sets speci®c for the N-terminal domains [sense ( (Whitehead et al., 1995) , whereas the numbering of Ost described in the text begins with the ®rst ATG in the open reading frame. All cDNA was also assessed using a primer set to amplify a 513 bp fragment of b-actin. DNA was ampli®ed in all reactions over 30 cycles (948C, 0.5 min, 558C, 0.5 min, 688C, 2 min) with the exception of the ampli®cation of the Ost-b2 isoform which was performed using 25 cycles.
Focus forming assays and generation of stable cell lines
Expression constructs (0.1 ± 1.0 mg/plate) were transfected into NIH3T3 ®broblasts in duplicate by the calcium phosphate method. Focus formation was observed in unselected plates approximately 14 days after transfection and quanti®ed by staining with Geimsa. Transforming activity was expressed as the number of foci produced (focus forming units, f.f.u.) per pmol DNA. Transfection eciency was determined by counting the number of colonies surviving in the presence of G418 (750 mg/ml) produced by each DNA construct. Mass cultures of cells stably expressing the recombinant proteins were obtained by transfection of the indicated DNA constructs (1 mg) followed by growth in G418.
Reporter gene assays
The construction of AP1-and SRF-luciferase reporter plasmids in pGL2Luc containing a minimal c-Fos promoter (756 to +109) has been described previously Kimmelman et al., 1997) . Luciferase reporter plasmids (1.5 mg) were cotransfected in duplicate with each expression vector (2.0 mg) into NIH3T3 ®broblasts by calcium phosphate precipitation and processed for luciferase activity. Following transfection all cells were subjected to serum starvation for 18 h and following this incubation certain cells were stimulated with 10% fetal calf serum or 100 ng/ml TPA (Gibco ± BRL) for 6 h to assess the activity of the reporter plasmids. Luciferase activity in cellular lysates was determined in duplicate, normalized to protein content and was expressed as relative luciferase units (RLU) as described previously . To rule out potential dierences in transfection eciency, the reproducibility of these results was con®rmed by cotransfection of pRL-TK (Promega), an internal reporter plasmid derived from a Renilla luciferase construct whose expression is directed by a thymidine kinase promotor, which was used to independently normalize luciferase activity. No signi®cant dierences in RLU activity obtained by normalization to protein content or pRL-TK activity (data not shown).
Western blotting and kinase assays
Activated p38 and p42/p44 MAP kinases were analysed in protein lysates (150 mg/lane) prepared from transfectants of Ost or vector by Western blotting as described . All cells were deprived of serum for 18 h prior to analysis unless otherwise indicated. Cells were stimulated with bFGF (50 ng/ml), anisomycin (12.5 mg/ml), UV (33 J/ m 2 ) or 10% fetal calf serum (FCS) prior to preparation of lysates where indicated. Ost expression was detected in NIH3T3 cells stably transfected with Ost isoforms using anti-Ost antisera (1 : 3000, Horii et al., 1994) . Endogenous JNK activity was assayed in NIH3T3 cell transfectants expressing the Ost isoforms as described (Coso et al., 1995) . JNK activity was quanti®ed by scanning densitometry and normalized to JNK protein levels. Cyclin and CDK expression levels were assessed by Western blot analysis using straight lysates prepared from serum-starved NIH3T3 cells expressing the indicated constructs using antibodies prepared against Cyclin A, D1 or CDK5 (Santa Cruz Biotechnologies). [ 125 I] Protein A was used to detect and quantify bound antibody.
In situ mRNA hybridization
Ost isoform speci®c DNA probes were generated for the SH3 domain, TR domain and BI domain by PCR and subcloned into pGEM11Z at BamHI and EcoRI sites. Antisense and sense riboprobes were prepared using [ 33 P]UTP and T7 and SP6 RNA polymerases, respectively, by standard methods. Coronal sections of adult mouse brain or sagittal sections of embryonic day 12 and 17 embryos were obtained from adult or timed-pregnant BALB/C mice (Charles River), respectively. Tissue preparation, sectioning and in situ hybridization analysis were performed as described previously (Sassoon and Rosenthal, 1993) . Both sense and antisense riboprobes were hybridized and processed to each tissue specimen independently. Autoradiography was performed with Kodak NT/B2 emulsion and signals were developed following 10 days exposure. Sections were examined and photographed using dark and bright ®eld optics.
DNA constructs
Human Cdc42, Racl, or RhoA cDNA constructs encoding dominant negative, activating, or wild-type sequences as well as H-Ras V12 and Ost-a have been described elsewhere (Horii et al., 1994; Coso et al., 1995) . Full-length Ost-g was isolated by screening a cDNA library in lpCEV29 prepared from the mouse hematopoietic cell line, 32D, using a 0.8 kb BamHI fragment of Ost-a. The ®rst 337 amino acids of fulllength Ost-g were removed by digestion with NruI (in the 5' adaptor sequence for pCEV29) and EcoRI (within the Ost coding sequence) and religation to create Ost-g(T). All DNA expression constructs were subcloned into the expression vector pCEV29.
